Osteopathische Behandlungsaspekte bei COVID-19

Es war das Ziel der Autoren, die sich mit der Studie befasst haben, den potenziellen Einfluss von osteopathischen Behandlungen (osteopathic manipulative treatment, OMT) auf jeden relevanten Aspekt von COVID-19 zu untersuchen, um die präventive, kurative und palliative Rolle zu bestimmen, welche die Osteopathen in dieser Pandemie und ähnlichen zukünftigen Situationen spielen könnten. Anmerkung: Die Abkürzung OMT bezeichnet im englisch-amerikanischen Sprachraum sowohl die parietale und viszerale als auch die kraniosakrale Osteopathie und damit sämtliche Behandlungstechniken, von der Gelenkmanipulation bis hin zu biodynamischen Herangehensweisen.

Publication History

Article published online:
10 January 2022

• Literatur

• 1 Licciardone JC, Brimhall AK, King LN. Osteopathic manipulative treatment for lowback pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 2005; 6: 43
• 2 European Centre for Disease Prevention and Control. Situation update worldwide, as of 13 April 2020. Epidemiological update. Im Internet (Stand: 13.11.2021): http://www.ecdc.europa.eu/en/covid-19/surveillance/weekly-surveillance-report
• 3 Bordoni B, Zanier E. Understanding fibroblasts in order to comprehend the osteopathic treatment of the fascia. Evid Based Complement Alternat Med 2015; 2015: 860934
• 4 Meltzer KR, Standley PR. Modeled repetitive motion strain and indirect osteopathic manipulative techniques in regulation of human fibroblast proliferation and interleukin secretion. J Am Osteopath Assoc 2007; 107: 527-536
• 5 Ward EA. Influenza and its osteopathic management. 1937. J Am Osteopath Assoc 2000; 100: 325-328
• 6 Patterson MM. The coming influenza pandemic: lessons from the past for the future. J Am Osteopath Assoc 2005; 105: 498-500
• 7 Hruby RJ, Hoffman KN. Avian influenza: an osteopathic component to treatment. Osteopath Med Prim Care 2007; 1: 10
• 8 Xu H, Zhong L, Deng J. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12: 8
• 9 South AM, Diz D, Chappell MC. COVID-19, ACE2 and the cardiovascular consequences. Am J Physiol Circ Physiol 2020; 318: 1084-1090
• 10 Castillo R, Schander A, Hodge LM. Lymphatic pump treatment mobilizes bioactive lymph that suppresses macrophage activity in vitro. J Am Osteopath Assoc 2018; 118: 455-461
• 11 Hodge LM, King HH, Williams AG. et al. Abdominal lymphatic pump treatment increases leukocyte count and flux in thoracic duct lymph. Lymphat Res Biol 2007; 5: 127-133
• 12 Hodge LM, Bearden MK, Schander A. et al. Lymphatic pump treatment mobilizes leukocytes from the gut associated lymphoid tissue into lymph. Lymphat Res Biol 2010; 8: 103-110
• 13 Hodge LM, Downey HF. Lymphatic pump treatment enhances the lymphatic and immune systems. Exp Biol Med 2011; 236: 1109-1115
• 14 Salminen S, Bouley C, Boutron M-C. et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 (S1): 147-171
• 15 Schander A, Fred Downey H, Hodge LM. Lymphatic pump manipulation mobilizes inflammatory mediators into lymphatic circulation. Exp BiolMed 2012; 237: 58-63
• 16 Walkowski S, Singh M, Puertas J. et al. Osteopathic manipulative therapy induces early plasma cytokine release and mobilization of a population of blood dendritic cells. PLoS One 2014; 10: e90132
• 17 Licciardone JC, Kearns CM, Hodge LM. et al. Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain: results from the osteopathic trial. J Am Osteopath Assoc 2012; 112: 596-605
• 18 Licciardone JC, Kearns CM, Hodge LM. et al. Osteopathic manual treatment in patients with diabetes mellitus and comorbid chronic low back pain: subgroup results from the OSTEOPATHIC trial. J Am Osteopath Assoc 2013; 113
• 19 Jackson KM, Steele TF, Dugan EP. et al. Effect of lymphatic and splenic pump techniques on the antibody response to hepatitis B vaccine: a pilot study. J Am Osteopath Assoc 1998; 98: 155-160
• 20 Hodge LM, Creasy C, Carter KR. et al. Lymphatic pump treatment as an adjunct to antibiotics for pneumonia in a rat model. J Am Osteopath Assoc 2015; 115: 306-316
• 21 Nikolich-Zugich J, Knox KS, Rios CT. et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. GeroSci 2020; 42: 505-514
• 22 Zanotti E, Berardinelli P, Bizzarri C. et al. Osteopathic manipulative treatment effectiveness in severe chronic obstructive pulmonary disease: a pilot study. Complement Ther Med 2012; 20: 16-22
• 23 Howell RK, Allen TW, Kappler RE. The influence of osteopathic manipulative therapy in the management of patients with chronic obstructive lung disease. J Am Osteopath Assoc 1974; 74: 757-760
• 24 Engel RM, Gonski P, Beath K. et al. Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): a randomized controlled pilot trial. J Man Manip Ther 2016; 24: 80-89
• 25 Herridge MS, Cheung AM, Tansey CM. et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693
• 26 Yang M, Yan Y, Yin X. et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst Rev 2013; (02) CD006338
• 27 Noll DR, Degenhardt BF, Johnson JC. Multicenter osteopathic pneumonia study in the elderly: Subgroup analysis on hospital length of stay, ventilator-dependent respiratory failure rate, and in-hospital mortality rate. J Am Osteopath Assoc 2016; 116: 574-587
• 28 Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158: 1518-1519
• 29 Zhang H, Kang Z, Gong H. et al. The digestive system is a potential route of 2019- nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bio-Rxiv 2020;
• 30 Pan L, Mu M, Yang P. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China. Am J Gastroenterol 2020; 115: 766-773
• 31 Hashimoto T, Perlot T, Rehman A. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487(7408): 477-481
• 32 Kassinen A, Krogius-Kurikka L, Mäkivuokko H. et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33
• 33 Liebregts T, Adam B, Bredack C. et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-920
• 34 Müller A, Franke H, Resch KL. et al. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review. J Am Osteopath Assoc 2014; 114: 470-479
• 35 Mao R, Liang J, Shen J. et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol 2020; 5: 426-428
• 36 Shi S, Qin M, Shen B. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5: 802-810
• 37 Inciardi RM, Lupi L, Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 819-824
• 38 O-Yurvati AH, Carnes MS, Clearfield MB. et al. Hemodynamic effects of osteopathic manipulative treatment immediately after coronary artery bypass graft surgery. J Am Osteopath Assoc 2005; 105: 475-481
• 39 Cerritelli F, Carinci F, Pizzolorusso G. et al. Osteopathic manipulation as a complementary treatment for the prevention of cardiac complications: 12-months follow-up of intima media and blood pressure on a cohort affected by hypertension. J Bodyw Mov Ther 2011; 15: 68-74
• 40 Li Z, Wu M, Yao J. et al. Caution on kidney dysfunctions of COVID-19 patients. SSRN Electron J 2020; 1-25
• 41 Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med 2020; 46: 846-848
• 42 Cheng Y, Luo R, Wang K. et al. Kidney disease is associated with in-hospital deathof patients with COVID-19. Kidney Int 2020; 97: 829-838
• 43 Bovo L, Burrai F, Canossa F. Use of complementary and alternative medicine in nephrology: a review of RCTs. G Tec Nefrol Dial 2017; 29: 185-192
• 44 Kaufman BE. An osteopathic approach to the renal and urinary system. Osteopath Fam Phys 2012; 4: 101-109
• 45 Tozzi P, Bongiorno D, Vitturini C. Low back pain and kidney mobility: local osteopathicfascial manipulation decreases pain perception and improves renal mobility. J Bodyw Mov Ther 2012; 16: 381-391
• 46 Mao L, Wang M, Chen S. et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurology 2020; 77: 683-690
• 47 Wu Y, Xu X, Chen Z. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22
• 48 Vaira LA, Salzano G, Deiana G. et al. Anosmia and Ageusia: common findings in COVID-19 patients. Laryngoscope 2020; 130: 1787
• 49 Brann D, Tsukahara T, Weinreb C. et al. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. Science Advances 2020; 6: eabc5801
• 50 Schmid A, Brunner F, Wright A, Bachmann LM. Paradigm shift in manual therapy? Evidence for a central nervous system component in the response to passive cervical joint mobilisation. Man Ther 2008; 13: 387-396
• 51 Tamburella F, Piras F, Piras F. et al. Cerebral perfusion changes after osteopathic manipulative treatment: a randomized manual placebocontrolled trial. Front Physiol 2019; 10: 403
• 52 Hitscherich K, Smith K, Cuoco JA. et al. The glymphatic-lymphatic continuum: opportunities for osteopathic manipulative medicine. J Am Osteopath Assoc 2016; 116: 170-177
• 53 Sherman T, Qureshi Y, Bach A. Osteopathic manipulative treatment to manage ophthalmic conditions. J Am Osteopath Assoc 2017; 117: 568-575
• 54 Yao S, Mikhail N, Koutsouras G. et al. Osteopathic considerations in the infections of the respiratory tract. Osteopath Fam Phys 2017; 9: 17-25
• 55 Apoznanski TE, Abu-Sbaih R, Terzella MJ. et al. Resolution of dacryostenosis after osteopathic manipulative treatment. J Am Osteopath Assoc 2015; 115: 110-114
• 56 Heinisch M, Oberhuber H. Die osteopathische Behandlung von Säuglingen zwischen dem 4. und 12. Lebensmonat mit kongenitaler Tränenwegsstenose. Eine randomisierte kontrollierte Studie. Ismaning: Europäisches Colleg für Osteopathie (COE); 2008
• 57 Lee-Wong M, Karagic M, Doshi A. et al. An osteopathic approach to chronic sinusitis. J Allergy Ther 2011;
• 58 Häfner S, Stadler M. Osteopathie und chronische Sinusitis – eine Pilotstudie. Ismaning: Europäisches Colleg für Osteopathie (COE); 2002
• 59 Roos S, Steinbauer U, Amann P. Können osteopathische Behandlungen die Symptomatik des Kopfschmerzes bzw. des Kopfdrucks bei Patienten mit chronischer Rhinosinusitis verbessern – eine randomisierte kontrollierte Studie. Ismaning: Europäisches Colleg für Osteopathie (COE); 2006